Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;42(2):373-383.
doi: 10.5534/wjmh.230004. Epub 2023 Aug 9.

Regulation of Phosphorylation of Glycogen Synthase Kinase 3α and the Correlation with Sperm Motility in Human

Affiliations

Regulation of Phosphorylation of Glycogen Synthase Kinase 3α and the Correlation with Sperm Motility in Human

Seung Hyun Park et al. World J Mens Health. 2024 Apr.

Abstract

Purpose: To unravel the mechanism regulating the phosphorylation of glycogen synthase kinase 3 (GSK3) and the correlation between the inhibitory phosphorylation of GSK3α and sperm motility in human.

Materials and methods: The phosphorylation and priming phosphorylated substrate-specific kinase activity of GSK3 were examined in human spermatozoa with various motility conditions.

Results: In human spermatozoa, GSK3α/β was localized in the head, midpiece, and principal piece of tail and p-GSK3α(Ser21) was enriched in the midpiece. The ratio of p-GSK3α(Ser21)/GSK3α was positively coupled with normal sperm motility criteria of World Health Organization. In high-motility spermatozoa, p-GSK3α(Ser21) phosphotyrosine (p-Tyr) proteins but p-GSK3α(Tyr279) markedly increased together with decreased kinase activity of GSK3 after incubation in Ca2+ containing medium. In high-motility spermatozoa, p-GSK3α(Ser21) levels were negatively coupled with kinase activity of GSK3, and which was deregulated in low-motility spermatozoa. In high-motility spermatozoa, 6-bromo-indirubin-3'-oxime, an inhibitor of kinase activity of GSK3 increased p-GSK3α(Ser21) and p-Tyr proteins. p-GSK3α(Ser21) and p-Tyr protein levels were decreased by inhibition of PKA and Akt. Calyculin A, a protein phosphatase-1/2A inhibitor, markedly increased the p-GSK3α(Ser21) and p-Tyr proteins, and significantly increased the motility of low-motility human spermatozoa.

Conclusions: Down regulation of kinase activity of GSK3α by inhibitory phosphorylation was positively coupled with human sperm motility, and which was regulated by Ca2+, PKA, Akt, and PP1. Small-molecule inhibitors of GSK3 and PP1 can be considered to potentiate human sperm motility.

Keywords: Glycogen synthase kinase 3; Humans; Phosphorylation; Sperm motility.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. Expression and phosphorylation of glycogen synthase kinase 3 (GSK3) in human spermatozoa. (A) In acrosome-intact (left) spermatozoa, GSK3α/β was expressed in the head (asterisks) and in the midpiece (arrows) and principal piece of the tail (arrowheads). p-GSK3α(Ser21) was expressed in the post-acrosomal region of the head and midpiece and tail. In acrosome-reacted (right) spermatozoa, GSK3α/β disappeared from the acrosomal and post-acrosomal regions of the head and was found in the equatorial region of the head (asterisks) and in the midpiece (arrows) and principal piece (arrowheads) of the tail. p-GSK3α(Ser21) was found in the midpiece of the tail. (B) Fluorescence intensity of GSK3α/β in acrosome-intact spermatozoa was significantly higher than those in acrosome-reacted spermatozoa whereas no significant change was observed in p-GSK3α(Ser21). GSK3α/β and p-GSK3α(Ser21) are green. Nuclei were stained blue by DAPI. Scale bar=5 µm. AU: arbitrary units. *Significantly different by Mann–Whitney U-test at p<0.05 levels.
Fig. 2
Fig. 2. Phosphorylation of glycogen synthase kinase 3 (GSK3) isoforms in human spermatozoa with different motility. (A) Representative western blot of GSK3 in human spermatozoa with different motility conditions. (B) Sperm motility of 40% was used as the criterion for normal motility according to the World Health Organization lower reference limit of human sperm motility. The ratio of p-GSK3α(Ser21)/GSK3α was positively correlated with human sperm motility. No significant difference in the ratio of p-GSK3α(Tyr279)/GSK3α, p-GSK3β(Tyr216)/GSK3β, p-GSK3α/β(Ser21/9)/GSK3α/β, and p-GSK3α/β(Tyr279/216)/GSK3α/β was found between the high-motility spermatozoa and low-motility spermatozoa. AU: arbitrary units, ND: not detected. *Significantly different from low-motility spermatozoa by Mann–Whitney U-test at p<0.05 levels. X and circles indicate mean and individual values, respectively.
Fig. 3
Fig. 3. Change in Ser21 phosphorylation and priming phosphorylated substrate-specific kinase activity of glycogen synthase kinase 3 (GSK3) after capacitation in human spermatozoa. (A) Efficacy of the priming phosphorylated peptide substrate (T-Pep(p)) in determining GSK3 kinase activity in sperm extracts. T-Pep showed no remarkable change in phosphorylation by recombinant GSK3 regardless of ATP. In contrast, T-Pep(p) was phosphorylated by recombinant GSK3 and ATP. T-Pep and T-Pep(p) were loaded in control (Con) lane for comparison. (B) Fluorescent gel kinase assay for GSK3 substrate specific kinase activity to T-Pep(p) in fresh human spermatozoa lysates. LiCl (0–10 mM) decreased GSK3 kinase activity in dose dependent manner. T-Pep(p) was loaded in Con lane without sperm extracts and LiCl. (C) Western blots of p-GSK3α(Ser21) and phosphotyrosine (p-Tyr) proteins in human spermatozoa after incubation in Tyrode’s basal medium (TBM) or Tyrode’s complete medium (TCM). p-GSK3α(Ser21) and p-Tyr proteins levels in spermatozoa incubated in TBM were lower than those incubated in TCM. (D) Gel kinase assay of GSK3 in high-motility human spermatozoa after incubation in TBM or TCM. Reduction of GSK3 kinase activity of spermatozoa following incubation was apparent in TCM compared to TBM. ATP: adenosine 5′-triphosphate, TAMRA: tetramethyl-6-carboxyrhodamine.
Fig. 4
Fig. 4. Change in Ser21 phosphorylation and priming phosphorylated substrate-specific kinase activity in human spermatozoa with different motility. (A) Fluorescent gel kinase assay of glycogen synthase kinase 3 (GSK3) from human spermatozoa with high and low-motility. After incubation in Tyrode’s complete medium (TCM), the kinase activity of GSK3 decreased in the high-motility spermatozoa but increased in the low-motility spermatozoa. T-Pep(pp) band intensities were measured by densitometric analysis and calculated as ratio compared to those of T-Pep(p). T-Pep, T-Pep(p), and T-Pep(pp) were loaded as marker. (B) Phosphorylation of GSK3 in low- and high-motility spermatozoa after incubation in TCM. p-GSK3α(Ser21), but not p-GSK3α(Tyr279), increased in the high-motility spermatozoa. In the low-motility spermatozoa, no visible change in p-GSK3 was observed. (C) The ratio of p-GSK3α(Ser21)/GSK3α was increased significantly after incubation in TCM, whereas the ratio of p-GSK3α(Tyr279)/GSK3α ratio was not. (D) Western blots of p-GSK3α(Ser21) and phosphotyrosine (p-Tyr) proteins after incubation with the 6-bromo-indirubin-3′-oxime (BIO), an inhibitor of GSK3 kinase activity in TCM. BIO (5–500 nM) increased p-GSK3α(Ser21) and p-Tyr proteins in a dose-dependent manner. AU: arbitrary units. **Significantly different from fresh spermatozoa by Mann–Whitney U-test (p<0.01).
Fig. 5
Fig. 5. Change in Ser21 phosphorylation of glycogen synthase kinase 3 (GSK3) and phosphotyrosine (p-Tyr) proteins in human spermatozoa by 8-bromoadenosine 3′,5′-cyclic monophosphate (8-br-cAMP), H89, and Akt inhibitor VIII treatment. (A) Western blots of p-GSK3(Ser21) and p-Tyr proteins in human spermatozoa after incubation with 8-br-cAMP in Tyrode’s basal medium (TBM) or Tyrode’s complete medium (TCM). 8-brcAMP (1 mM) increased p-GSK3α(Ser21) and p-Tyr proteins levels, and which was apparent in the spermatozoa incubated in TCM compared to those incubated in TBM. (B) Western blots of p-GSK3α(Ser21) and p-Tyr proteins after incubation with the PKA inhibitor H89 in TCM. H89 (100 µM) markedly decreased the levels of p-GSK3α(Ser21) and p-Tyr proteins in human spermatozoa. (C) Western blots of p-GSK3α(Ser21) and p-Tyr proteins after incubation with Akt inhibitor VIII in TCM. Akt inhibitor VIII (50–100 µM) markedly decreased the levels of the p-GSK3α(Ser21) and p-Tyr proteins after incubation in TCM.
Fig. 6
Fig. 6. Recovery of p-GSK3(Ser21), phosphotyrosine (p-Tyr) proteins and motility in low-motility human spermatozoa by Calyculin A. (A) Western blots of p-GSK3α(Ser21) and p-Tyr proteins in low-motility human spermatozoa following incubation with Calyculin A in Tyrode’s complete medium. Calyculin A (10 nM) markedly increased the levels of p-GSK3α(Ser21) and p-Tyr proteins in low-motility spermatozoa. (B) Effects of Calyculin A on low-motility human spermatozoa. Calyculin A (10 nM) significantly increased the progressive as well as total motility. GSK3: glycogen synthase kinase 3. *Significantly different from low-motility spermatozoa by Mann–Whitney U-test at p<0.05 levels.
Fig. 7
Fig. 7. Regulation of glycogen synthase kinase 3 (GSK3) in human spermatozoa. In human spermatozoa, inhibitory phosphorylation of GSK3α is tightly regulated by Ca2+, protein phosphatase-1 (PP1), PKA, and Akt, leading to capacitation and motility activation. Small-molecule inhibitors of GSK3 and PP1 can be considered as a potential therapeutic drug for treatment of low sperm motility in human.

Similar articles

Cited by

References

    1. Yu JS, Cui W. Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development. 2016;143:3050–3060. - PubMed
    1. Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, et al. The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism. J Biol Chem. 1999;274:17934–17940. - PubMed
    1. da Silva RM, Noce BD, Waltero CF, Costa EP, de Abreu LA, Githaka NW, et al. Non-classical gluconeogenesis-dependent glucose metabolism in Rhipicephalus microplus embryonic cell line BME26. Int J Mol Sci. 2015;16:1821–1839. - PMC - PubMed
    1. Medina M, Wandosell F. Deconstructing GSK-3: the fine regulation of its activity. Int J Alzheimers Dis. 2011;2011:479249. - PMC - PubMed
    1. Yao HB, Shaw PC, Wong CC, Wan DC. Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J Chem Neuroanat. 2002;23:291–297. - PubMed
-